Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Frankel

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Stroke|March 10, 2001
Clinical deterioration following improvement in the NINDS rt-PA Stroke TrialJ C Grotta, K M Welch, S C Fagan, et al.
Neurology|November 4, 2000
Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke TrialM R Frankel, L B Morgenstern, T Kwiatkowski, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
European Journal of Neurology|April 23, 2017
Stroke etiology and collaterals: atheroembolic strokes have greater collateral recruitment than cardioembolic strokesL C Rebello, M Bouslama, D C Haussen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
The care of HIV-infected adults in rural areas of the United StatesS E Cohn, M L Berk, S H Berry, et al.
AJNR. American Journal of Neuroradiology|April 6, 2001
Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onsetL Derex, T A Tomsick, T G Brott, et al.
The New England Journal of Medicine|December 24, 1998
The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study ConsortiumS A Bozzette, S H Berry, N Duan, et al.
Neurology|October 13, 2006
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASIDS E Kasner, M J Lynn, M I Chimowitz, et al.
Health Services Research|December 11, 1999
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sampleM R Frankel, M F Shapiro, N Duan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Stroke|March 10, 2001
Clinical deterioration following improvement in the NINDS rt-PA Stroke TrialJ C Grotta, K M Welch, S C Fagan, et al.
Neurology|November 4, 2000
Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke TrialM R Frankel, L B Morgenstern, T Kwiatkowski, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
European Journal of Neurology|April 23, 2017
Stroke etiology and collaterals: atheroembolic strokes have greater collateral recruitment than cardioembolic strokesL C Rebello, M Bouslama, D C Haussen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2001
The care of HIV-infected adults in rural areas of the United StatesS E Cohn, M L Berk, S H Berry, et al.
AJNR. American Journal of Neuroradiology|April 6, 2001
Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onsetL Derex, T A Tomsick, T G Brott, et al.
The New England Journal of Medicine|December 24, 1998
The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study ConsortiumS A Bozzette, S H Berry, N Duan, et al.
Neurology|October 13, 2006
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASIDS E Kasner, M J Lynn, M I Chimowitz, et al.
Health Services Research|December 11, 1999
National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sampleM R Frankel, M F Shapiro, N Duan, et al.
Pageof 3